These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
94 related articles for article (PubMed ID: 15598968)
1. Persistence with antihypertensives related to formulation: the case of nifedipine. Breekveldt-Postma NS; Herings RM Ann Pharmacother; 2005 Feb; 39(2):237-42. PubMed ID: 15598968 [TBL] [Abstract][Full Text] [Related]
2. A comparison of the effects of two modified release preparations of nifedipine-nifedipine retard 10 mg twice daily and nifedipine GITS 20 mg once daily--in the treatment of mild to moderate hypertension. Kirby BJ; Kitchin NR Int J Clin Pract; 1999; 53(5):339-43. PubMed ID: 10695096 [TBL] [Abstract][Full Text] [Related]
3. Comparative efficacy of two long-acting formulations of nifedipine in the treatment of hypertension. The Switch Study Investigators. Myers MG; Toal CB Can J Cardiol; 1995 Nov; 11(10):913-7. PubMed ID: 7489530 [TBL] [Abstract][Full Text] [Related]
4. Determinants of persistence with bisphosphonates: a study in women with postmenopausal osteoporosis. Penning-van Beest FJ; Goettsch WG; Erkens JA; Herings RM Clin Ther; 2006 Feb; 28(2):236-42. PubMed ID: 16678644 [TBL] [Abstract][Full Text] [Related]
5. Differences in antihypertensive drug persistence associated with drug class and gender: a PHARMO study. Erkens JA; Panneman MM; Klungel OH; van den Boom G; Prescott MF; Herings RM Pharmacoepidemiol Drug Saf; 2005 Nov; 14(11):795-803. PubMed ID: 16178043 [TBL] [Abstract][Full Text] [Related]
6. Dose- and administration time-dependent effects of nifedipine gits on ambulatory blood pressure in hypertensive subjects. Hermida RC; Calvo C; Ayala DE; López JE; Rodríguez M; Chayán L; Mojón A; Fontao MJ; Fernández JR Chronobiol Int; 2007; 24(3):471-93. PubMed ID: 17612946 [TBL] [Abstract][Full Text] [Related]
7. Enhanced persistence with tiotropium compared with other respiratory drugs in COPD. Breekveldt-Postma NS; Koerselman J; Erkens JA; Lammers JW; Herings RM Respir Med; 2007 Jul; 101(7):1398-405. PubMed ID: 17368011 [TBL] [Abstract][Full Text] [Related]
8. A double-blind, controlled, multicenter, randomized study comparing the antihypertensive effectiveness and tolerance of a daily dose of two nifedipine formulations: nifedipine microgranules versus nifedipine osmotic pump. de Roa ER; Botero R; Octavio JA; Berrizbeitia ML; Mayorca E; Castro P; Miranda R; Valecillo E; Aroca G; Aza G; González M Am J Ther; 2007; 14(2):140-6. PubMed ID: 17414581 [TBL] [Abstract][Full Text] [Related]
9. Chronotherapy with nifedipine GITS in hypertensive patients: improved efficacy and safety with bedtime dosing. Hermida RC; Ayala DE; Mojón A; Fernández JR Am J Hypertens; 2008 Aug; 21(8):948-54. PubMed ID: 18600215 [TBL] [Abstract][Full Text] [Related]
15. Generic substitution of antihypertensive drugs: does it affect adherence? Van Wijk BL; Klungel OH; Heerdink ER; de Boer A Ann Pharmacother; 2006 Jan; 40(1):15-20. PubMed ID: 16303985 [TBL] [Abstract][Full Text] [Related]
16. Once daily nifedipine: the formulation dictates the pharmacokinetic characteristics and the therapeutic responses. Toal CB; Meredith PA; Elliott HL Int J Clin Pharmacol Ther; 2012 Mar; 50(3):202-17. PubMed ID: 22373833 [TBL] [Abstract][Full Text] [Related]
17. [Evaluation of a combination of a diuretic and nifedipine retard for the treatment of hypertensive patients refractory to nifedipine retard]. Martínez López JJ; Rúiz López FJ; Gómez Márquez M; Ortega González G; Molina Boix M; Florenciano Sánchez R An Med Interna; 1993 Aug; 10(8):386-9. PubMed ID: 8218783 [TBL] [Abstract][Full Text] [Related]
18. Tolerability of high doses of lercanidipine versus high doses of other dihydropyridines in daily clinical practice: the TOLERANCE Study. Barrios V; Escobar C; de la Figuera M; Llisterri JL; Honorato J; Segura J; Calderón A Cardiovasc Ther; 2008; 26(1):2-9. PubMed ID: 18466416 [TBL] [Abstract][Full Text] [Related]
19. Doxazosin GITS versus standard doxazosin in mild to moderate hypertension. Calvo C; Gil-Extremera B; Gomez-Fernández P; Masramon X; Pueyo C; Armada B Int J Cardiol; 2005 May; 101(1):97-104. PubMed ID: 15860390 [TBL] [Abstract][Full Text] [Related]
20. Uric acid and other renal function parameters in patients with stable angina pectoris participating in the ACTION trial: impact of nifedipine GITS (gastro-intestinal therapeutic system) and relation to outcome. Ruilope LM; Kirwan BA; de Brouwer S; Danchin N; Fox KA; Wagener G; Segura J; Poole-Wilson PA; Lubsen J; J Hypertens; 2007 Aug; 25(8):1711-8. PubMed ID: 17620970 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]